FierceBiotech Mar 2, 2026 Cullgen ditches reverse merger with Pulmatrix to go with Gyre in $300M buyout
FierceBiotech Mar 2, 2026 TCE biotech Candid scores Nasdaq listing via reverse merger with rare disease-focused Rallybio
FierceBiotech Mar 2, 2026 Boehringer axes MASH deal with OSE as biotech continues to whittle down pipeline
Thermo Fisher Mar 2, 2026 Thermo Fisher Scientific: Recovery In Life Sciences Solutions (NYSE:TMO) - Seeking Alpha
Agilent Mar 2, 2026 Assessing Agilent Technologies (A) Valuation After Recent Share Price Softness and Long Term Gains - Yahoo Finance
Endpoints News Mar 2, 2026 United Therapeutics to take pulmonary hypertension drug to FDA for approval
Endpoints News Mar 2, 2026 Aardvark's stock plummets on study pause; BioNTech heads to Phase 3 with DualityBio ADC